Meningococcal B

Clinical Resources

Materials for Providers

Alphabetical by Title

Meningococcal B Vaccine Recommendations by Age and Risk Factor

This piece gives recommendations for MenB vaccine use in people age 10 years or older.

Standing Orders for Administering Meningococcal B Vaccine to Adolescents and Adults

Eligible healthcare professionals may vaccinate adolescents and adults who meet any of the criteria on this form

Materials for Vaccine Recipients

Alphabetical by Title

Meningococcal: Questions and Answers

Information about the disease and vaccines for patients and parents

View all Clinical Resources

CDC · FDA · State

ACIP Recommendations

Current Recommendations

Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023
MMWR April 18, 2024 / 73(15);345–350
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices
MMWR, September 25, 2020, Volume 69(9); 1–41

Vaccine Information Statements

Meningococcal B VIS
Updated: August 6, 2021

FDA Package Inserts & EUAs

Meningococcal B: Bexsero Package Insert
Meningococcal B: Trumenba Package Insert

More from

Unprotected People Stories’s MenB Vaccination Honor Roll

Preventing Outbreaks of Meningitis B in Colleges and Universities urges colleges and universities to establish policies requiring or recommending meningococcal serogroup B (MenB) vaccination to protect their students and prevent outbreaks.’s MenB Vaccination Honor Roll recognizes champion institutions that have taken the lead in establishing such policies.

Learn more about the program

View the honor roll

This page was updated on .